Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204416 | SCV000261259 | benign | DICER1-related tumor predisposition | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000370848 | SCV000389762 | likely benign | Pleuropulmonary blastoma | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000494483 | SCV000581592 | benign | Hereditary cancer-predisposing syndrome | 2016-06-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001812208 | SCV002048502 | benign | not provided | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000494483 | SCV002532460 | benign | Hereditary cancer-predisposing syndrome | 2020-09-10 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV002465564 | SCV002760791 | benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002465564 | SCV002774357 | benign | not specified | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001812208 | SCV004130330 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | DICER1: BP4, BS1, BS2 |